SummitTX Capital’s Sotera Health SHC Stock Holding History

SummitTX Capital’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,000	Closed	-$236K	–	939
2025 Q3	$236K	Buy	+15,000	New	+$211K	0.01%	678

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SummitTX Capital's SHC Position: Q4 2025 in Review

SummitTX Capital sold out of Sotera Health (SHC) in Q4 2025, closing a stake of 15,000 shares — an estimated $236K sold.

SummitTX Capital first reported a position in SHC in Q3 2025 and held it in 1 quarter. The position peaked at $236K in Q3 2025. 285 funds tracked by Wall St. Rank hold SHC as of Q4 2025.

SummitTX Capital reported no remaining Sotera Health position as of Q4 2025 after selling out during the quarter.
SummitTX Capital sold 15,000 Sotera Health shares in Q4 2025, an estimated $236K.
SummitTX Capital first reported a position in Sotera Health in Q3 2025 and held it in 1 quarter.
SummitTX Capital's Sotera Health position peaked at $236K in Q3 2025.
285 funds tracked by Wall St. Rank held Sotera Health as of Q4 2025.

Based on SummitTX Capital's 13F filing for Q4 2025, filed 17 Feb 2026.